MAI Wealth Advisors »

Oncolytics Biotech shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $736 526 1.40
2025-06-30 $407 526 0.77
2025-03-31 $289 526 0.55
2024-12-31 $480 526 0.91

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Oncolytics Biotech

Citadel Advisors
Marshall Wace
Seeds Investor
Goldman Sachs Group
International Assets Investment Management
Franklin Resources
Royal Bank of Canada
Geode Capital Management
CIBC World Markets
LPL Financial
Headinvest
Badgley Phelps Wealth Managers
Bank Of Montreal
Ball & Co Wealth Management
SeaCrest Wealth Management

View all funds holding Oncolytics Biotech